http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006282581-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_132435e46cf3d954e74d0e7cc7fe3ad1 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-305 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate | 2005-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a4690a7adc4ebb77fe60bd6f35eb966 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2530eadd522e41e4a3ce9f78b95d7ba7 |
| publicationDate | 2006-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2006282581-A |
| titleOfInvention | Tryptophan metabolic intermediates effective in suppressing Chlamydia spp. |
| abstract | 【Task】 An object of the present invention is to provide substances that effectively suppress infection or growth of Chlamydia bacteria and methods for using these substances. [Solution] The present invention provides a pharmaceutical composition or a food composition characterized by suppressing infection or growth of Chlamydia bacteria and comprising a tryptophan metabolic intermediate product as an active ingredient. |
| priorityDate | 2005-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 52.